Royersford, PA, United States of America

Craig Alan Coburn

USPTO Granted Patents = 58 


 

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 287(Granted Patents)

Forward Citations (Not Self Cited) = 267(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Skippack, PA (US) (1998 - 2003)
  • West Point, PA (US) (2015)
  • Royersford, PA (US) (2000 - 2017)
  • Seattle, WA (US) (2019 - 2020)
  • Novato, CA (US) (2017 - 2021)
  • San Rafael, CA (US) (2015 - 2022)

Company Filing History:


Years Active: 1998-2022

Loading Chart...
Loading Chart...
Loading Chart...
58 patents (USPTO):

Title: Craig Alan Coburn: Innovator in Therapeutics and Viral Inhibitors

Introduction

Craig Alan Coburn is a distinguished inventor based in Royersford, PA, known for his significant contributions to the field of therapeutics. With an impressive portfolio of 58 patents, Coburn has focused on developing innovative solutions to combat a variety of medical challenges, particularly in the areas of infectious diseases and neurological disorders.

Latest Patents

Among Craig Coburn's latest inventions are two notable patents that highlight his commitment to addressing critical health issues. The first patent, titled "Inhibitors of Lysine Gingipain," pertains to therapeutics aimed at targeting the bacterium responsible for certain infections, including brain disorders such as Alzheimer’s disease. This invention introduces compounds according to a specific formula and their corresponding pharmaceutically acceptable salts, offering potential new avenues for treatment.

The second patent, "Inhibitors of Hepatitis C Virus Replication," presents compounds designed to inhibit the NS5A protein of the hepatitis C virus (HCV). This research emphasizes the synthesis of these compounds and their application in preventing HCV infections and viral replication within cell-based systems. Both patents demonstrate Coburn's innovative approach to tackling pressing medical challenges through chemical and pharmaceutical advancements.

Career Highlights

Craig Alan Coburn has had a fruitful career, notably with reputable organizations such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His roles in these companies have surely enhanced his expertise and expanded his impact in the pharmaceutical industry. Coburn's work not only reflects his personal dedication to innovation but also underlines the importance of collaboration in scientific research and development.

Collaborations

Throughout his career, Craig Coburn has worked alongside talented professionals such as Joseph P. Vacca and Shawn J. Stachel. These collaborations have likely facilitated the exchange of ideas and expertise, further enriching the research landscape and advancing the development of new therapeutic solutions.

Conclusion

In conclusion, Craig Alan Coburn stands out as a prominent inventor whose work has significantly influenced advancements in the development of therapeutics and viral inhibitors. With a robust portfolio of patents and a strong background in the pharmaceutical industry, Coburn continues to contribute to the ongoing fight against diseases that impact millions. His inventions not only showcase his innovative spirit but also hold promise for future medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…